Skip to main content
Log in

Cyclophosphamide

Urinary tract cancer: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L.Incidence and predictors of urotoxic adverse events in cyclophosphamide- treated patients with systemic necrotizing vasculitides. Arthritis and Rheumatism 63: 1435-1445, No. 5, May 2011. Available from: URL: http://dx.doi.org/10.1002/art.30296 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyclophosphamide. React. Wkly. 1355, 14 (2011). https://doi.org/10.2165/00128415-201113550-00042

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113550-00042

Keywords

Navigation